Can Miralax (polyethylene glycol) cause colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Miralax Cause Colitis?

No, there is no evidence that Miralax (polyethylene glycol 3350) causes colitis. The FDA-approved drug label for polyethylene glycol does not list colitis as a side effect, and there are no clinical guidelines or research studies that establish a causal link between Miralax and colitis 1.

Understanding Miralax (Polyethylene Glycol 3350)

Miralax is an osmotic laxative that works by:

  • Drawing water into the colon to soften stool and increase bowel movements
  • Being poorly absorbed in the intestinal tract
  • Working through an osmotic mechanism rather than through irritation of the intestinal lining

Common Side Effects

According to the FDA drug label, the most common side effects of Miralax include:

  • Loose, watery, more frequent stools 1
  • Bloating
  • Abdominal discomfort
  • Nausea

Safety Profile

Miralax has been extensively studied and has demonstrated a favorable safety profile:

  • Clinical studies have shown it to be safe and effective for the treatment of constipation 2
  • It does not cause significant electrolyte abnormalities even when used in higher doses 3
  • It has been safely used in both adults and children 4

Colitis: Causes and Risk Factors

Colitis (inflammation of the colon) is typically caused by:

  • Inflammatory bowel diseases like ulcerative colitis
  • Infections (bacterial, viral, or parasitic)
  • Ischemia (reduced blood flow to the colon)
  • Medications (NSAIDs, antibiotics)
  • Radiation therapy

Medications Known to Cause Colitis

Several medications have been associated with colitis, but polyethylene glycol is not among them:

  • Bisacodyl has been associated with rare occurrences of ischemic colitis 5
  • Alosetron (a 5-HT3 receptor antagonist used for IBS-D) was temporarily withdrawn from the market due to reports of ischemic colitis 5
  • Docetaxel-containing regimens have been reported to cause ischemic colitis in rare cases 5

Clinical Considerations When Using Miralax

When to Use Caution

The FDA label recommends asking a doctor before using Miralax if you have:

  • Nausea, vomiting, or abdominal pain
  • A sudden change in bowel habits lasting over 2 weeks
  • Irritable bowel syndrome 1

Appropriate Use

  • Miralax is commonly used as a bowel preparation for colonoscopy, often in combination with other agents 5, 6, 7
  • It's also used for the treatment of constipation at lower doses (17-34g daily) 2
  • For bowel preparation, split-dosing regimens have shown better efficacy than single-dose regimens 3

Bowel Preparation Considerations

When using Miralax for bowel preparation:

  • Split-dose regimens are more effective than single-dose regimens 3
  • Traditional PEG with electrolytes (GoLytely) has shown superior bowel cleansing compared to Miralax/Gatorade combinations, though patients prefer the taste of Miralax 6, 7
  • Miralax has not been shown to cause significant electrolyte disturbances even when used in higher doses for bowel preparation 3

Bottom Line

Miralax is a safe osmotic laxative that works by drawing water into the colon. It has not been associated with causing colitis in clinical studies or post-marketing surveillance. If a patient develops symptoms of colitis while taking Miralax, other causes should be investigated, as the association is likely coincidental rather than causal.

References

Research

Overnight efficacy of polyethylene glycol laxative.

The American journal of gastroenterology, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

MiraLAX is not as effective as GoLytely in bowel cleansing before screening colonoscopies.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.